SENSEX    72234.74       -254.25    |    NIFTY    21925.95       -69.90 FAQ    |    Feedback
EQUITIES
DERIVATIVES
IPO
Gainers & Losers Value & Volume Toppers 52 Weeks High/Low Advances & Declines
New High-Low
Pre-Session Mid-Session End-Session Other Markets Market Beat Stock Alert
Hot Pursuit Foreign Markets Economy News Corporate News Corporate Results
Detailed Quotes Board of Directors Balance Sheet Profit & Loss Quarterly Results Historical Price
Financial Ratios Company Background Technical Chart
Announcements Book Closure Board Meetings Bonus Issues Rights Issues
De-Listed Shares Name Change Split of Face Value Market Turnover
FII Investments MF Investments ADR Prices World Indices
Forthcoming IPOs
Open IPOs
Closed IPOs
New Listing
Basis Of Allotment Draft Prospectus New Issue Monitor
Get Quotes
Gainers
Losers
Value Toppers Advances & Declines Ticker Spot
Ticker Futures Closing Price Technical Chart Commodity News MCX Currency Futures
Get Quotes NIFTY Futures Top Traded Value Top Quantity Most Active Contracts
FII Statistics Daily Settlement Price List of Underlyings Put Call Ratio Derivative Summary
All Index Futures Top Gainers Top Losers Most Active Put Most Active Call
Highest in OI Lowest in OI Increase in OI Decrease in OI
Stock Alert
Overall view of all the recent market developments which will help in your investment decisions
Cipla in spotlight after South African regulator's approval for HIV drug
12-Sep-18   08:16 Hrs IST

Cipla said it received approval for its HIV treatment combination medicine 'TLD' from the South African Health Products Regulatory Authority (SAHPRA). The drug will be manufactured at Cipla's facilities in Durban and Uganda. The announcement was made after market hours yesterday, 11 September 2018.

Sun Pharmaceutical Industries will be watched. With reference to the media report, Sun Pharma's Mohali plant on FDA radar, the drug major clarified that the US Food and Drug Administration (USFDA) is conducting an inspection of the company's Mohali facility (Punjab, India). The inspection started yesterday, 10 September 2018 and is ongoing. The clarification was issued after market hours yesterday, 11 September 2018.

Wipro and Duck Creek Technologies, the P&C insurance industry's leading Saas software provider, announced a relationship whereby Wipro will offer a broad array of implementation services and related software and data solutions for its insurance industry customers around the world. Wipro will offer systems integration, configuration, and support services for the Duck Creek Platform, which includes solutions for policy, rating, billing, claims, data insights, and digital engagement. Together, Wipro and Duck Creek will help insurers meet rapidly evolving consumer expectations in their digital transformation journey. The announcement was made after market hours yesterday, 11 September 2018.

Redington (India) announced that a meeting of the board of directors of the company is fixed on 17 September 2018 in Chennai, to consider a proposal to buyback the fully paid-up equity shares of the company. The announcement was made after market hours yesterday, 11 September 2018.

Godrej Agrovet announced that the meeting of the board of directors of the company is scheduled on 14 September 2018, to consider and approve scheme of amalgamation of Astec LifeSciences, a subsidiary of the company, with the company and also to discuss on business strategies. The announcement was made after market hours yesterday, 11 September 2018.

Powered by Capital Market - Live News

MARKETS
TODAY'S MARKET SECTOR
BSE NSE
Currencies
Currency EUR GBP INR USD
Europe (EUR) 1.00 0.86 89.02 1.06
United Kingdom (GBP) 1.17 1.00 104.11 1.24
India (INR) 0.01 0.01 1.00 0.01
United States (USD) 0.94 0.80 83.63 1.00
Market News << ALL News
  19-Apr-2024, (11:32 )  Indo Count acquires ..
  19-Apr-2024, (11:00 )  Volumes spurt at Bir..
  19-Apr-2024, (10:44 )  ITC arm inks pact to..
  19-Apr-2024, (10:42 )  ICICI Securities Q4 ..
 Commodities << ALL Commodities
   Attention Investor: Prevent unauthorized transactions in your trading / Demat account : Update your mobile number / e mail ids with your stock broker / deposit." | "No need to issue cheques by investors while subscribing to IPO.Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account." | "KYC is one time exercise while dealing in securities markets- once KYC is done through a SEBI registered intermediary(broker, DP, Mutual Fund etc.) you need not undergo the same process again when you approach another intermediary."
   Disclaimer   |   BSE Disclosure  |  Privacy Policy   |   Investor Protection   |    Inactive Account   |  Vernacular Language: NSE | BSE   |   Feedback   |    PMLA Policy   |   Risk Management Policy   |   Insider Trading   |   Investor Grivenances   |   Investor Complaints   |   Investor Charter   |   Rules And Regulations   |   Broker Norms   |   Terms of Use    Policies & Procedures   |   Risk Disclosure   |   Do & Don’ts   |   Rights & Obligations
  
SEBI Registration No : INZ000267132   |   BSE Clearing No : 333   
   Copyright © 2011 All rights reserved by Jaysukhlal Jagjivan Stock Broking Pvt.Ltd Designed, Developed & Powered By CMOTS INFOTECH (ISO 9001:2015 certified)